The global clinical nutrition market size was estimated at US$ 38 billion in 2023 and is expected to reach over US$ 70.33 billion by 2032 and growing at a noteworthy CAGR of 6.40% from 2023 to 2032.
Access our Premium Real Time Data Intelligence Tool, Visit: Precedence Statistics
The U.S. clinical nutrition market size was valued at US$ 10.37 billion in 2022 and is predicted to grow around US$ 19.38 billion by 2032 and growing at a noteworthy CAGR of 6.50% from 2023 to 2032.
Based on the region, the North America segment dominated the global clinical nutrition market in 2022, in terms of revenue and is estimated to sustain its dominance during the forecast period. Due to significant research and development spending, the presence of large businesses and their product availability, and the region’s well established healthcare infrastructure.
On the other hand, the Asia-Pacific is estimated to be the most opportunistic segment during the forecast period. The governments are spending in the construction of healthcare infrastructure; the Asia-Pacific is predicted to have the greatest CAGR during the forecast period.
The nutrition of patients in the healthcare industry is referred to as clinical nutrition. The goal of clinical nutrition is to help patients maintain a good energy balance while also giving essential nutrients such as minerals, vitamins, and protein. Clinical nutrition has several advantages, including its effectiveness in treating diabetes and its ability to help people live better at any age. Clinical nutrition products are given to people who are unable to absorb or chew food products.
The rise in the incidence of chronic diseases, the number of patients using sophisticated clinical nutritional products, and the growing concern about malnutrition in pediatric patients is all driving the clinical nutrition market growth. The market for clinical nutrition is expected to grow as the elderly population grows and the number of patients suffering from malnutrition grows. Additionally, changing consumer preferences in food consumption, as well as rising demand for nutritional products, are likely to boost the growth of the clinical nutrition market during the forecast period.
The growing consumer awareness of the importance of nutrition for health is driving the global clinical nutrition market. Clinical nutrition sales are being driven by expanding product lines, a constant newborn birth rate, an ageing population, and a variety of other variables around the world. The growing awareness of the connection between health and nutrition, as well as enhancing market conditions, has fueled the expansion of the clinical nutrition market. Furthermore, revenues are expected to be driven by new advances in follow up formulae, product improvements, and other organic formulas over the projection period.
However, obstacles such as government regulatory frameworks, a lack of standard global reimbursement policies combined with economic uncertainty, and the prevalence of patient compliance challenges are projected to stifle global clinical nutrition market expansion. The increasing government measures to improve the current healthcare system, on the other hand, could open up new chances for the clinical nutrition market in the coming years.
One of the primary reasons likely to have a major impact on the overall growth of the global clinical nutrition market is changing consumer patterns in terms of diet and consumption of various nutritional products. With increased internet penetration and availability to digital media, consumer awareness of the benefits of clinical nutrition is on the rise, which is expected to boost the global clinical nutrition market during the forecast period.
While consumer awareness continues to rise, market players are expected to adhere to a strict regulatory framework and focus on product development strategies in order to gain permission from the relevant regulatory body. Several competitors in the current clinical nutrition market are considering extending their product portfolios and production capabilities in order to meet the rising demand for clinical nutrition, especially in the developed regions.
|Market Size||US$ 70.33 Billion by 2032|
|Growth Rate||CAGR of 6.40% from 2023 to 2032|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Forecast Period||2023 to 2032|
|Segments Covered||Route of Administration, End User, Application, Region|
|Companies Mentioned||Abbott Laboratories, B. Braun Melsungen AG., Mead Johnson Nutrition Company, Perrigo Company Plc., H.J. Heinz Company, Hospira Inc., Groupe Danone, Fresenius Kabi AG, Baxter International Inc., Nestle SA|
Based on the route of administration, the oral dominates the clinical nutrition market during the forecast period. The increased focus on maintaining a robust immune system has resulted in an increase in demand for oral clinical supplements. The use of oral nutrition in combating malnutrition will contribute to the oral clinical nutrition segment growth.
On the other hand, the parental is expected to grow at rapid pace during the forecast period. The rising frequency of malnutrition among children, particularly in emerging and underdeveloped nations around the world, is one of the primary factors expected to boost demand for parental nutrition.
Based on the application, the metabolic disorders dominate the clinical nutrition market during the forecast period. The demand for clinical nutrition is increasing as the prevalence of metabolic diseases rises. Obesity, diabetes, malnutrition, and cardiovascular diseases contribute to increased hospitalization.
On the other hand, the cancer is expected to grow at rapid pace during the forecast period. Cancer is becoming more common, and people are becoming more aware of the importance of clinical nutrition in cancer treatment. Cancer is one of the top causes of death around the world
Based on the end user, the pediatric dominates the clinical nutrition market during the forecast period. This is attributed to the global incidence of malnutrition and related issues. Malnutrition is a major cause of high mortality and morbidity, particularly in developing and underdeveloped nations.
On the other hand, the geriatric is expected to grow at rapid pace during the forecast period. The geriatric population faces number of disorders. The geriatric population is above 65 years, who requires good amount of nutrition. This factor is driving the growth of the segment.
Key Companies & Market Share Insights
For expansion and diversification, these significant market players place a premium on strategic activities such as new product launches, collaborations, partnerships, and commercialization. Moreover, these industry leaders are heavily spending in research to enable them to introduce novel products to the market and maximize income and profit. Nestle Health Science signed agreement to buy IM HealthScience in August 2020. As public awareness of clinical nutrition grows, so does demand for adult and pediatric nutrition formulae. As a result, key market players are working to provide nutritional solutions that meet all of the needs of the target population around the world.
Segments Covered in the Report
By Route of Administration
By End User
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client